COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,903 Articles (22,568 medRxiv, 8,335 bioRxiv)

Most recent first Previous |  Page 2186: Articles 21851-21860  | Next

Detection of SARS-CoV-2 within the healthcare environment: a multicentre study conducted during the first wave of the COVID-19 outbreak in England
Moore, G., Rickard, H., Stevenson, D., Aranega Bou, P., Pitman, J., Crook, A., Davies, K., Spencer, A., Burton, C., Easterbrook, L., Love, H. E., Summers, S., Welch, S. R., Wand, N., Thompson, K.-A., Pottage, T., Richards, K. S., Dunning, J., Bennett, A.
10.1101/2020.09.24.20191411 — Posted: 2020-09-25 Discussion: Onsite
The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: transmission model-based future scenario analysis and economic evaluation
Sandmann, F., Davies, N., Centre for the Mathematical Modelling of Infectious Diseases COVID-19 working group, , Vassall, A., Edmunds, W. J., Jit, M.
10.1101/2020.09.24.20200857 — Posted: 2020-09-25
SCOAT-Net: A Novel Network for Segmenting COVID-19 Lung Opacification from CT Images
Zhao, S., Li, Y., Li, Z., Chen, Y., Zhao, W., Xingzhi, X., Liu, J., Zhao, D.
10.1101/2020.09.23.20191726 — Posted: 2020-09-25
Impact of Personal Care Habits on Post-Lockdown COVID-19 Contagion: Insights from Agent-based Simulations
Alvarez-Pomar, L., Rojas-Galeano, S.
10.1101/2020.09.23.20200212 — Posted: 2020-09-25
Public health information on COVID-19 for international travellers: Lessons learned from a rapid mixed-method evaluation in the UK containment phase
Zhang, T., Robin, C., Cai, S., Sawyer, C., Rice, W., Smith, L. E., Amlot, R., Rubin, G. J., Reynolds, R., Yardley, L., Hickman, M., Oliver, I., Lambert, H.
10.1101/2020.09.22.20195628 — Posted: 2020-09-25
Electrostatic filters to reduce COVID-19 spread in bubble CPAP: an in vitro study of safety and efficacy.
Davis, J. W., Pillow, J. J., Cooper, M., Dahl, M. J.
10.1101/2020.09.23.20200485 — Posted: 2020-09-25
Combinations of PCR and isothermal amplification techniques are suitable for fast and sensitive detection of SARS-CoV-2 viral RNA
Varlamov, D. A., Blagodatskikh, K. A., Smirnova, E. V., Kramarov, V. M. V., Ignatov, K. B.
10.1101/2020.09.23.20200055 — Posted: 2020-09-25
A vaccine built from potential immunogenic pieces derived from the SARS-CoV-2 spike glycoprotein
Marchan, J. G.
10.1101/2020.09.24.312355 — Posted: 2020-09-24
Functional genomic screens identify human host factors for SARS-CoV-2 and common cold coronaviruses
Wang, R., Simoneau, C. R., Kulsuptrakul, J., Bouhaddou, M., Travisano, K., Hayashi, J. M., Carlson-Stevermer, J., Oki, J., Holden, K., Krogan, N. J., Ott, M., Puschnik, A. S.
10.1101/2020.09.24.312298 — Posted: 2020-09-24
An evolutionary portrait of the progenitor SARS-CoV-2 and its dominant offshoots in COVID-19 pandemic
Kumar, S., Tao, Q., Weaver, S., Sanderford, M. D., Caraballo, M., Sharma, S., Kosakovsky Pond, S. L., Miura, S.
10.1101/2020.09.24.311845 — Posted: 2020-09-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).